Tag Archives: Royalty

Voting for ‘None of the Above’ At Elan

The latest development at Elan is that the Company went to court to block Royalty Pharma‘s buyout bid, which says something about their confidence that they can make the case to their own shareholders. The shareholders deserve something better than … Continue reading

Posted in Uncategorized | Tagged , , , | Leave a comment

Elan: If You Can’t Beat Them, Be Them

Freud (Anna, not her father) coined the psychoanalytic term ‘identification with the aggressor’ to describe a process wherein an individual identifies with–and emulates–the behavior of someone they experience as a threat, in order to feel less vulnerable. Elan has now … Continue reading

Posted in Big Pharma, BioFollies, Biotech | Tagged , , , | Leave a comment